CureVac strikes COVID-19 vaccine alliance deal with Bayer

This post was originally published on this site

“Bayer will contribute its expertise and established infrastructure in areas such as clinical operations, regulatory affairs, pharmacovigilance, medical information, supply chain performance as well as support in selected countries,” they said.

Financial terms were not disclosed.

Add Comment